María Rubio Valera and Ignacio Aznar, from Parc Sanitari Sant Joan de Déu, took part in the XLIV Conference of the Spanish Health Economics Association (AES), held on June 20 in Madrid, with a presentation on the costs of cancer diagnosis in Colombia, Chile, and Ecuador, as part of the EquityCancer-LA project.
Under the theme “Health strategies for a global future: effectiveness, efficiency, and sustainability”, more than 250 economists and health professionals gathered at the Faculty of Economic and Business Sciences of the Complutense University of Madrid. This edition of the conference addressed major challenges faced by health systems today: population ageing, the rise in chronic diseases, the shortage of healthcare professionals, the impact of climate change, and the digital transformation, including the emergence of artificial intelligence. All of this takes place in a context that demands financial sustainability and a reduction in inequalities.
From Parc Sanitari Sant Joan de Déu, researchers María Rubio and Ignacio Aznar participated in the session Health Technology Assessment with the oral presentation “Cost of cancer diagnosis in fragmented health systems: An analysis of Chile, Colombia, and Ecuador”, where they shared findings on the estimated costs of diagnosing the most common cancers within public health networks in these countries.
The results highlight the economic burden on both patients and health systems, and the need to reduce costs and diagnostic delays, in order to promote more equitable and efficient cancer care in the region.
This work is part of the EquityCancer-LA project and was co-authored by Paula Arroyo-Uriarte and Ignacio Aznar-Lou from the Sant Joan de Déu Research Institute, Maria-Luisa Vázquez and Ingrid Vargas from the Consorci de Salut i Social de Catalunya, Pamela Eguiguren from the School of Public Health Dr. Salvador Allende Gossens, Faculty of Medicine, University of Chile, Amparo-Susana Mogollón-Pérez from the School of Medicine and Health Sciences, Universidad del Rosario, Patricia Granja from the Public Health Institute at Pontificia Universidad Católica del Ecuador, Signe Smith Jervelund from the Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Julian Perelman from NOVA National School of Public Health, Public Health Research Centre, NOVA University Lisbon, Josep M. Borràs from the University of Barcelona and the Catalonian Cancer Plan, Department of Health, Spain; Bellvitge Biomedical Research Institute (IDIBELL), and María Rubio-Valera from the PRISMA Research Group on Primary Healthcare and Mental Health at the Sant Joan de Déu Research Institute (IRSJD), CIBERESP, and the Faculty of Medicine and Health Sciences at the University of Barcelona.